These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19632708)

  • 1. Prognostic significance and treatment implications of positive peritoneal cytology in endometrial adenocarcinoma: Unraveling a mystery.
    Wethington SL; Barrena Medel NI; Wright JD; Herzog TJ
    Gynecol Oncol; 2009 Oct; 115(1):18-25. PubMed ID: 19632708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of peritoneal cytology in low-intermediate risk endometrial cancer.
    Scott SA; van der Zanden C; Cai E; McGahan CE; Kwon JS
    Gynecol Oncol; 2017 May; 145(2):262-268. PubMed ID: 28359690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical implications of positive peritoneal cytology in endometrial cancer].
    Ren YL; Wang HY; Shan BE; Ping B; Shi DR
    Zhonghua Fu Chan Ke Za Zhi; 2011 Aug; 46(8):595-9. PubMed ID: 22169518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of prognostic factors in stage IIIA endometrial cancer.
    Mariani A; Webb MJ; Keeney GL; Aletti G; Podratz KC
    Gynecol Oncol; 2002 Jul; 86(1):38-44. PubMed ID: 12079298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer.
    Havrilesky LJ; Cragun JM; Calingaert B; Alvarez Secord A; Valea FA; Clarke-Pearson DL; Berchuck A; Soper JT
    Gynecol Oncol; 2007 Feb; 104(2):401-5. PubMed ID: 17014898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy.
    Sonoda Y; Zerbe M; Smith A; Lin O; Barakat RR; Hoskins WJ
    Gynecol Oncol; 2001 Mar; 80(3):378-82. PubMed ID: 11263935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive peritoneal cytology is highly predictive of prognosis and relapse patterns in stage III (FIGO 2009) endometrial cancer.
    Milgrom SA; Kollmeier MA; Abu-Rustum NR; Makker V; Gardner GJ; Barakat RR; Alektiar KM
    Gynecol Oncol; 2013 Jul; 130(1):49-53. PubMed ID: 23603151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer.
    Havrilesky LJ; Secord AA; O'Malley DM; Broadwater G; Bae-Jump V; Cohn DE; Gehrig PA
    Gynecol Oncol; 2009 Aug; 114(2):279-83. PubMed ID: 19446319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of surgical resection extent on the prognosis of clinical stage I endometrial carcinoma].
    Yan X; Gao YN; Jiang GQ; Gao M; An N
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):208-12. PubMed ID: 19615262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials.
    Bosse T; Peters EE; Creutzberg CL; Jürgenliemk-Schulz IM; Jobsen JJ; Mens JW; Lutgens LC; van der Steen-Banasik EM; Smit VT; Nout RA
    Eur J Cancer; 2015 Sep; 51(13):1742-50. PubMed ID: 26049688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of lymph vascular space invasion on recurrence and survival in patients with early stage endometrial cancer.
    Loizzi V; Cormio G; Lorusso M; Latorre D; Falagario M; Demitri P; Scardigno D; Selvaggi LE
    Eur J Cancer Care (Engl); 2014 May; 23(3):380-4. PubMed ID: 24112088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection].
    Ivanov I
    Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative cervical cytology in endometrial carcinoma and its clinicopathologic relevance.
    Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H; Yamasaki F
    Gynecol Oncol; 1999 Mar; 72(3):273-7. PubMed ID: 10053095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of body mass index on clinicopathologic features, surgical morbidity and outcome in patients with endometrial cancer.
    Akbayır O; Corbacıoglu Esmer A; Numanoglu C; Cılesız Goksedef BP; Akca A; Bakır LV; Kuru O
    Arch Gynecol Obstet; 2012 Nov; 286(5):1269-76. PubMed ID: 22729137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of peritoneal cytology in uterine cervix and endometrial cancer.
    Kashimura M; Sugihara K; Toki N; Matsuura Y; Kawagoe T; Kamura T; Kaku T; Tsuruchi N; Nakashima H; Sakai H
    Gynecol Oncol; 1997 Dec; 67(3):285-90. PubMed ID: 9441776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant Treatment after Surgery in Stage IIIA Endometrial Adenocarcinoma.
    Yoon MS; Huh SJ; Kim HJ; Kim YS; Kim YB; Kim JY; Lee JH; Kim HJ; Cha J; Kim JH; Kim J; Yoon WS; Choi JH; Chun M; Choi Y; Lee KK; Kim M; Jeong JU; Chang SK; Park W
    Cancer Res Treat; 2016 Jul; 48(3):1074-83. PubMed ID: 26511800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
    Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal cytology: a risk factor of recurrence for non-endometrioid endometrial cancer.
    Han KH; Park NH; Kim HS; Chung HH; Kim JW; Song YS
    Gynecol Oncol; 2014 Aug; 134(2):293-6. PubMed ID: 24854062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.